S2747A

	2014 -- S 2747 SUBSTITUTE A
	========
	LC005115/SUB A
	========
	STATE OF RHODE ISLAND
	IN GENERAL ASSEMBLY
	JANUARY SESSION, A.D. 2014
	____________
	A N A C T
	RELATING TO BUSINESS AND PROFESSIONS -- PHARMACIES--COMPOUNDED
	PRESCRIPTION LABELING

	Introduced By: Senators Felag, Walaska, and Lombardi
	Date Introduced: March 06, 2014
	Referred To: Senate Health & Human Services
	It is enacted by the General Assembly as follows:
1	SECTION 1. Chapter 5-19.1 of the General Laws entitled "Pharmacies" is hereby
2	amended by adding thereto the following section:
3	5-19.1-32. Compounded drugs used in office. -- (a) Prescription drugs that are not
4	commercially available may be compounded for physician's office use, but shall not be resold.
5	All compounding shall be done in compliance with the United States Pharmacopeia and as
6	defined by the board.
7	(b) Upon request, a pharmacy shall provide a compounded drug to a practitioner for
8	administration in a physician's office. The compounded drug shall be for practitioner
9	administration only and shall not be redispensed, pursuant to § 5-19.1-21. The practitioner shall
10	not be required to provide the name of an individual patient in order for the pharmacy to dispense
11	the compounded drug, and the pharmacy shall include the statement "Not for resale. For office
12	use only" on the label of any such compounded drug. The pharmacy shall maintain records to
13	indicate what compounded drug products the pharmacy provided to the practitioner.
14	SECTION 2. This act shall take effect upon passage.
	========
	LC005115/SUB A
	========

	EXPLANATION
	BY THE LEGISLATIVE COUNCIL
	OF
	A N A C T
	RELATING TO BUSINESS AND PROFESSIONS -- PHARMACIES--COMPOUNDED
	PRESCRIPTION LABELING
	***
1	This act would permit a pharmacy to provide a compounded drug to a practitioner for
2	administration in a physician's office.
3	This act would take effect upon passage.
	========
	LC005115/SUB A
	========
	LC005115/SUB A - Page 2 of 1